Early versus Late Recurrence of Hepatocellular Carcinoma after Microwave Ablation: Patterns, Treatments, and Post-Recurrence Survival
Oncology · 2024
DOI: 10.1159/000536542 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology, 2024. Verfasst von Jing Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cancer Biology and Xijing Hospital of Digestive Diseases, Air Force Medical University, Xi'an, China, zj210224@163.com. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Microwaves, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Recurrence after microwave ablation (MWA) has not been extensively studied. We aimed to investigate the patterns, treatments, and survival of patients with hepatocellular carcinoma (HCC) who experienced early and late recurrence after MWA.
Methods
This retrospective study included patients with HCC recurrence after MWA as the initial treatment from January 2008 to December 2021. Recurrence patterns, treatments, and outcomes between patients with early and late HCC recurrence were compared. Prognostic factors of post-recurrence survival (PRS) were identified by multivariable Cox regression analyses.
Results
Among 222 patients, 128 developed early recurrence (≤2 years after MWA) and 94 had late recurrence (>2 years). Majority of the recurrent HCC were intrahepatic-only recurrence, within the Milan criteria, and received potentially curative treatment. No significant differences in the recurrence patterns, vascular invasion, tumor staging, post-recurrence treatments, or median PRS (35.0 vs. 33.0 months, p = 0.523) were identified between patients with early and late recurrence. Multivariable analyses suggested that multiple tumor number (hazard ratio [HR]: 1.54; 95% CI: 1.03–2.30, p = 0.038), extrahepatic recurrence (HR: 2.14, 95% CI: 1.16–3.92, p = 0.015), vascular invasion (HR: 2.37, 95% CI: 1.18–4.76, p = 0.038), and higher ALBI grade (HR: 2.18, 95% CI: 1.54–3.08, p < 0.001) were independent risk factors of worse PRS, while curative treatment after recurrence (HR: 0.59, 95% CI: 0.38–0.92, p = 0.020) was associated with better PRS.
Conclusions
No differences in recurrence patterns, post-recurrence treatments, or PRS were found between HCC patients with early and late recurrence following MWA. Tumor burden and patients’ liver function reserve should be considered to decide the optimal post-recurrence treatment after MWA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Cancer Biology and Xijing Hospital of Digestive Diseases, Air Force Medical University, Xi'an, China, zj210224@163.com.
- State Key Laboratory of Cancer Biology and Xijing Hospital of Digestive Diseases, Air Force Medical University, Xi'an, China.
Zitieren
APA
Zhang, J., Guo, G., Li, T., Guo, C., Han, Y., & Zhou, X. (2024). Early versus Late Recurrence of Hepatocellular Carcinoma after Microwave Ablation: Patterns, Treatments, and Post-Recurrence Survival. Oncology. https://doi.org/10.1159/000536542
Vancouver
Zhang J, Guo G, Li T, Guo C, Han Y, Zhou X. Early versus Late Recurrence of Hepatocellular Carcinoma after Microwave Ablation: Patterns, Treatments, and Post-Recurrence Survival. Oncology. 2024. doi:10.1159/000536542
BibTeX
@article{Zhang2024,
author = {Zhang, Jing and Guo, Guanya and Li, Tao and Guo, Changcun and Han, Ying and Zhou, Xinmin},
title = {Early versus Late Recurrence of Hepatocellular Carcinoma after Microwave Ablation: Patterns, Treatments, and Post-Recurrence Survival},
journal = {Oncology},
year = {2024},
doi = {10.1159/000536542}
}
EUVIMED